Browse 1,243 multiple myeloma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 1,243
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: The Bronx NY, Newark NJ, New Brunswick NJ, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05172245
Phase1, Recruiting
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
for
Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8,
Location: Scottsdale AZ
Sponsor: Mayo Clinic
Sex: Male
Age: 18+
Code: NCT07025369
Phase2, Recruiting
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03819296
Phase1, Recruiting
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
for
Localized Clear Cell Renal Cell Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07226544
Phase2, Recruiting
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
Location: Bath ME, Portland ME, Scarborough ME, South Portland ME,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase3, Recruiting
Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18 - 70+
Code: NCT07474090
Recruiting
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC, Durham NC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05843253
Phase2, Recruiting
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
for
Breast Cancer, Prostate Cancer, Colorectal Cancer,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07225309
Recruiting
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
for
Metastatic Prostate Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Male
Age: 18+
Code: NCT05487846
Recruiting
Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
for
Non-small Cell Lung Cancer Stage III,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07104630
Phase2, Recruiting
Chronic CED of TPT for Recurrent Malignant Glioma
for
Brain Tumor, Recurrent, Malignant Glioma (WHO Grade III or IV),
Location: New York NY
Sponsor: Jeffrey N. Bruce
Sex: All
Age: 18+
Code: NCT06666712
Phase1, Recruiting
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
for
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT04947254
Phase2, Recruiting
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
for
Muscle Invasive Bladder Carcinoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07579195
Phase1, Phase2, Recruiting
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
for
Endometrial Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT07062016
Recruiting
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT06999798
Phase1, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors
for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: Female
Age: 18+
Code: NCT07699991
Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
for
Hereditary Leiomyomatosis and Renal Cell Carcinoma,
Location: Bethesda MD, Columbus OH, Atlanta GA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT04981509
Phase2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,